Should all human immunodeficiency virus-infected patients with end-stage renal disease be excluded from transplantation? The views of US transplant centers

被引:77
作者
Spital, A [1 ]
机构
[1] Univ Rochester, Sch Med, Rochester, NY USA
关键词
D O I
10.1097/00007890-199805150-00008
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. Human immunodeficiency virus (HIV)infected patients have generally been excluded from transplantation. Recent advances in the management and prognosis of these patients suggest that this policy should be reevaluated. Methods. To explore the current views of U.S. transplant centers toward transplanting asymptomatic HIV-infected patients with end-stage renal disease, a written survey was mailed to the directors of transplantation at all 248 renal transplant centers in the United States. Results. All 148 responding centers said they require HIV testing of prospective kidney recipients, and 84% of these centers would not transplant an individual who refuses HIV testing. The vast majority of responding centers would not transplant a kidney from a cadaveric (88%) or a living donor (91%) into an asymptomatic HIV-infected patient who is otherwise a good candidate for transplantation. Among the few centers that would consider transplanting an HIV-infected patient, not a single cen ter had performed such a transplant in the year priori to the survey. Most centers fear that transplantation in the face of HIV infection would be harmful to the individual, and some believe that it would be a waste of precious organs. Conclusions. The great majority of U.S. renal transplant centers will not transplant kidneys to HIV-infected patients with end-stage renal disease, even if their infection is asymptomatic. However, advances in the management of HIV infection and a review of relevant ethical issues suggest that this approach should be reconsidered.
引用
收藏
页码:1187 / 1191
页数:5
相关论文
共 36 条
[1]  
BARRI YM, 1991, CLIN TRANSPLANT, V5, P233
[2]  
BEAUCHAMP TL, 1994, PRINCIPLES BIOMEDICA, P326
[3]  
Beauchamp Tom L., 1994, PRINCIPLES BIOMEDICA, V189, P226
[4]  
BOYD AS, 1990, NEW ENGL J MED, V323, P1492, DOI 10.1056/NEJM199011223232120
[5]   ETHICAL CONSIDERATIONS IN THE ALLOCATION OF ORGANS AND OTHER SCARCE MEDICAL RESOURCES AMONG PATIENTS [J].
CLARKE, OW ;
GLASSON, J ;
EPPS, CH ;
PLOWS, CW ;
RUFF, V ;
AUGUST, A ;
KLIGER, CM ;
WILKINS, GT ;
COSGRIFF, JH ;
ORENTLICHER, D ;
HARWOOD, K ;
LESLIE, J .
ARCHIVES OF INTERNAL MEDICINE, 1995, 155 (01) :29-40
[6]  
DAgati V, 1997, J AM SOC NEPHROL, V8, P138
[7]  
DANOVITCH G, 1990, ANN INTERN MED, V112, P35
[8]   HIV-1 protease inhibitors - A review for clinicians [J].
Deeks, SG ;
Smith, M ;
Holodniy, M ;
Kahn, JO .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 277 (02) :145-153
[9]   INFECTION WITH HUMAN IMMUNODEFICIENCY VIRUS IN THE PITTSBURGH TRANSPLANT POPULATION - A STUDY OF 583 DONORS AND 1043 RECIPIENTS, 1981-1986 [J].
DUMMER, JS ;
ERB, S ;
BREINIG, MK ;
HO, M ;
RINALDO, CR ;
GUPTA, P ;
RAGNI, MV ;
TZAKIS, A ;
MAKOWKA, L ;
VANTHIEL, D ;
STARZL, TE .
TRANSPLANTATION, 1989, 47 (01) :134-139
[10]  
FEDUSKA NJ, 1990, TRANSPLANT REV, V4, P93